Global NGS Newborn Genetic Testing /Screening Market
According to a new market research report published by Global Market Estimates, the Global NGS Newborn Genetic Testing /Screening Market is projected to grow at a CAGR of 17.5% from 2022 to 2027. LifeCell International Pvt. Ltd, BGI, PerkinElmer Genomics, CENTOGENE N.V., CryoCell International, Fulgent Genetics, Igenomix, Veritas Intercontinental, GENEPATH, and MedGenome among others, are some key players in the NGS newborn genetic testing /screening market.
Browse 155 Market Data Tables and 117 Figures spread through 183 Pages and in-depth TOC on “Global
NGS
Newborn
Genetic
Testing
/Screening
Market
-
Forecast
to
2027’’
https://www.globalmarketestimates.com/market-report/ngs-newborn-genetic-testing-screening-market-3831
By Sample Type (Blood, Saliva, and Others), By Application (Inherited & Other Disorders Screening/ Testing and Pharmacogenomics), By End-use (Hospitals & Clinics, Diagnostic Centers, and Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis
Sample Type Outlook (Revenue, USD Million, 2022-2027)
Blood
Saliva
Others
Application Outlook (Revenue, USD Million, 2022-2027)
Inherited & Other Disorders Screening/ Testing
Pharmacogenomics
End-use Outlook (Revenue, USD Million, 2022-2027)
Hospitals & Clinics
Diagnostic Centers
Others (Pharma & Research and Academic Institutes)
Regional Outlook (Revenue, USD Million, 2022-2027) North America
The U.S. Canada Mexico
Europe
Germany UK France Spain Italy Rest of Europe
Asia Pacific
China
India Japan South Korea Rest of APAC
Central & South America
Brazil Rest of CSA
Middle East & Africa
Saudi Arabia South Africa Rest of MEA
Contact: Yash Jain Email address: yash.jain@globalmarketestimates.com
Phone Number: +1 6026667238